AGOS Joins the National Strategy to Close the Women’s Health Gap

In July, AGOS was invited to join the Women First Research Coalition (WFRC), the Society for Women’s Health Research (SWHR) the American College of Obstetricians and Gynecologists (ACOG) to lend our endorsement to a landmark federal initiative: the National Strategy to Close the Women’s Health Gap.

This initiative is a call on Congress to make a transformational investment in women’s health and an opportunity for organizations across different women’s health issues to come together in support of efforts that will improve the lives of millions of Americans and their families. The women’s health gap is not only a matter of equity—it is an investment in the health, productivity, and economic strength of our nation.

In short, this will call on Congress to make a $20 billion ten-year strategic commitment in America that will close the women’s health gap. While this effort is aspirational, we also believe it’s a necessary investment that we will continue to push across Congressional sessions and Administrations.

The National Strategy to Close the Women’s Health Gap is structured around five pillars of investment:

  • Research and Innovation
  • Regulatory Coordination and Modernization
  • Clinical and Research Workforce
  • Data and Evidence Infrastructure
  • Public Awareness and Education

More information can be found here.

Warner K. Huh

Warner K. Huh, MD, MSHA is Chair of the Department of Obstetrics and Gynecology and holds the Charles E. Flowers, Jr. Endowed Chair in the Department of Obstetrics and Gynecology at the University of Alabama at Birmingham (UAB). He is also Professor in the Department of Surgery and Professor in the Department of Epidemiology in the UAB School of Public Health. He was previously the Division Director of Gynecologic Oncology, Vice Chair of Gynecology, and Chief Medical Officer of the UAB Cancer Service Line/O’Neal Comprehensive Cancer Center. His research interests include screening and prevention of HPV related diseases as well as novel immunotherapeutic approaches for pre-invasive disease of the cervix as well as cervical cancer. He has authored or co-authored over 300 articles in journals including The New England Journal of Medicine, Lancet, Lancet Oncology, Journal of the National Cancer Institute Cancer, Clinical Cancer Research, Gynecologic Oncology, Obstetrics & Gynecology, and the American Journal of Obstetrics & Gynecology (h-index: 70). Dr. Huh serves as co-PI (MPI) of the Johns Hopkins-UAB-University of Colorado Cervical Cancer Specialized Programs of Research Excellence (SPORE) program (2P50CA098252-06A1) – one of the most enduring SPORE programs in the NCI. Further, he is PI on a cervical cancer prevention R01 grant through the NCI (5R01CA279021). Dr. Huh serves as a Deputy Editor of Gynecologic Oncology and serves as an Associate Editor of The Journal of Lower Genital Tract Disease. He is on the steering committee for the ASCCP treatment guidelines and was co-chair of the ASCCP colposcopy standards effort. He is Past President of the Society of Gynecologic Oncology (SGO) and ASCCP. He is currently serves on the American Board of Obstetrics and Gynecology (ABOG) Division of Gynecologic Oncology. He recently completed the Executive Master of Science in Health Administration (MSHA) Program at UAB (2022-2024). He co-leads OPERATION WIPEOUT- the only state-based cervical cancer elimination effort in the United States.